vTv Therapeutics Inc. (VTVT) earnings date, market-implied expected move, and options open interest by expiry

earnings room

31.46−1.06%

Next report

fiscal Q3 2026

Nov 9

after close · estimated date

days out

Intraday

+0.52% since 10 AM

High 31.46 at 4:00 pm ET, low 31.20 at 10:30 am ET.

Revenue flow

Q1 FY2026 as filed

VTVT kept 65.51% of Q1 FY2026 revenue as profit.

Revenue$37M

Gross profit$37M100.00%

Operating income$23M63.15%

Pre-tax income$24M

Net income$24M65.51%

Cost of revenue

$0 · 0.00%

Operating expenses

$14M · 36.85%

Tax

$0 · 0.00%

Other income joins

$871,000 · 2.36%

Standardized lines from VTVT’s own filing for the quarter ended Mar 31 '26. Ribbon thickness is the dollar amount.

Expected move

No options chain priced for this ticker yet.

Linked exposure

placeholder

No linked names measured for this ticker yet.

Positioning

placeholder

No options positioning captured for this ticker yet.

Earnings history

implied in pale · realized in full ink

Q2 FY26—

+2.20%—

3-quarter memory

Event sensitivity

release-day history · not a forecast

FOMCrate decision1.3×up 8 of 24±5.2% vs ±3.9% · 24
NFPjobs report1.0×up 3 of 9±4.0% vs ±3.9% · 9
CPIconsumer prices1.0×up 5 of 9±3.8% vs ±3.9% · 9
PCEpersonal income & outlays0.8×up 7 of 16±3.2% vs ±3.9% · 16
PPIproducer prices0.8×up 5 of 9±3.2% vs ±3.9% · 9
GDPgross domestic product0.6×up 7 of 17±2.3% vs ±3.9% · 17
CPROFcorporate profits0.5×up 4 of 10±2.1% vs ±3.9% · 10

Past release days against VTVT’s ordinary ±3.9% day, from our own stored closes. History, not a forecast; kinds with fewer than six releases are omitted.

Track VTVT

Watchlist prices, news filtered to it, and its next report on your desk.

Market-implied ranges describe what current option prices imply, never a forecast. Prices via Intrinio.